Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.
Keitoku T, Tamaki N, Kurosaki M, Inada K, Kirino S, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Ishido S, Yamada M, Nobusawa T, Matsumoto H, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Asahina Y, Okamoto R, Izumi N. Keitoku T, et al. J Viral Hepat. 2023 Apr;30(4):297-302. doi: 10.1111/jvh.13805. Epub 2023 Jan 24. J Viral Hepat. 2023. PMID: 36648382
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma.
Matsumoto H, Tsuchiya K, Nakanishi H, Hayakawa Y, Yasui Y, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Ishido S, Yamada M, Keitoku T, Nobusawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Kurosaki M, Asahina Y, Okamoto R, Izumi N. Matsumoto H, et al. Among authors: keitoku t. Cancers (Basel). 2022 Jul 21;14(14):3551. doi: 10.3390/cancers14143551. Cancers (Basel). 2022. PMID: 35884610 Free PMC article.
Placebo Adverse Events in Non-alcoholic Steatohepatitis Clinical Trials: A Pooled Analysis of 2,944 Participants.
Tay PWL, Ng CH, Lin SY, Chin YH, Xiao J, Lim WH, Lim SY, Fu CE, Chan KE, Quek J, Tan DJH, Chew N, Syn N, Keitoku T, Tamaki N, Siddiqui MS, Noureddin M, Muthiah M, Huang DQ, Loomba R. Tay PWL, et al. Among authors: keitoku t. Am J Gastroenterol. 2023 Apr 1;118(4):645-653. doi: 10.14309/ajg.0000000000002042. Epub 2022 Sep 30. Am J Gastroenterol. 2023. PMID: 36191268 Free PMC article.
Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis.
Tan DJH, Quek SXZ, Yong JN, Suresh A, Koh KXM, Lim WH, Quek J, Tang A, Tan C, Nah B, Tan E, Keitoku T, Muthiah MD, Syn N, Ng CH, Kim BK, Tamaki N, Ho CSH, Loomba R, Huang DQ. Tan DJH, et al. Among authors: keitoku t. Clin Mol Hepatol. 2022 Oct;28(4):864-875. doi: 10.3350/cmh.2022.0136. Epub 2022 Jul 25. Clin Mol Hepatol. 2022. PMID: 36263668 Free PMC article.
Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma.
Ishido S, Tsuchiya K, Kano Y, Yasui Y, Takaura K, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Matsumoto H, Nobusawa T, Keitoku T, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Nakanishi H, Sakurai U, Asahina Y, Okamoto R, Kurosaki M, Izumi N. Ishido S, et al. Among authors: keitoku t. Cancers (Basel). 2023 Jan 24;15(3):719. doi: 10.3390/cancers15030719. Cancers (Basel). 2023. PMID: 36765676 Free PMC article.
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.
Ishido S, Tamaki N, Takahashi Y, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Matsumoto H, Nobusawa T, Keitoku T, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Tsuchiya K, Nakanishi H, Kurosaki M, Izumi N. Ishido S, et al. Among authors: keitoku t. BMC Gastroenterol. 2023 Jun 17;23(1):211. doi: 10.1186/s12876-023-02848-7. BMC Gastroenterol. 2023. PMID: 37330485 Free PMC article.
Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.
Ishido S, Tamaki N, Inada K, Itakura J, Takahashi Y, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Matsumoto H, Nobusawa T, Keitoku T, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Tsuchiya K, Nakanishi H, Kurosaki M, Izumi N. Ishido S, et al. Among authors: keitoku t. Clin Case Rep. 2023 Jul 5;11(7):e7664. doi: 10.1002/ccr3.7664. eCollection 2023 Jul. Clin Case Rep. 2023. PMID: 37415592 Free PMC article.
Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B.
Ishido S, Tamaki N, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Yamada M, Matsumoto H, Nobusawa T, Keitoku T, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Itakura J, Kurosaki M, Izumi N. Ishido S, et al. Among authors: keitoku t. JGH Open. 2023 Jul 21;7(8):567-571. doi: 10.1002/jgh3.12950. eCollection 2023 Aug. JGH Open. 2023. PMID: 37649865 Free PMC article.
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.
Yamada-Shimizu M, Tamaki N, Kurosaki M, Uchihara N, Suzuki K, Tanaka Y, Miyamoto H, Ishido S, Nobusawa T, Matsumoto H, Keitoku T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Izumi N. Yamada-Shimizu M, et al. Among authors: keitoku t. Intern Med. 2024 May 1;63(9):1185-1190. doi: 10.2169/internalmedicine.2248-23. Epub 2023 Sep 29. Intern Med. 2024. PMID: 37779070 Free PMC article.
Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease.
Suzuki K, Tamaki N, Kurosaki M, Takahashi Y, Yamazaki Y, Uchihara N, Tanaka Y, Miyamoto H, Yamada M, Keitoku T, Okada R, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Yasui Y, Tsuchiya K, Nakanishi H, Izumi N. Suzuki K, et al. Among authors: keitoku t. Hepatol Res. 2024 Jun;54(6):600-605. doi: 10.1111/hepr.14011. Epub 2024 Jan 17. Hepatol Res. 2024. PMID: 38234088
14 results